Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 43

Trial Status

Completed1
Other2

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT04920682Phase 4Completed
Reversal of Moderate or Superficial Neuromuscular Blockade Induced by Cisatracurium
Muscle WeaknessNeostigmineNeuromuscular Blocking Agents
PrincipalinvestigatorStart date: 2021-06-01
NCT05037006Phase 4Unknown
Three Different Doses of Neostigmine on the Reversal of Cisatracurium-induced Moderate Neuromuscular Blockade
Neuromuscular BlockadeNeuromuscular Blockade, Residual
Principalinvestigator
NCT05053594Phase 4Unknown
Different Doses of Neostigmine for Reversal of Moderate Neuromuscular Blockade in Children
Neuromuscular Block ProlongedNeuromuscular Block, ResidualNeuromuscular Blockade
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT04920682Phase 4PrincipalInvestigator

Reversal of Moderate or Superficial Neuromuscular Blockade Induced by Cisatracurium

Muscle WeaknessNeostigmineNeuromuscular Blocking Agents
Completed
NCT05037006Phase 4PrincipalInvestigator

Three Different Doses of Neostigmine on the Reversal of Cisatracurium-induced Moderate Neuromuscular Blockade

Neuromuscular BlockadeNeuromuscular Blockade, Residual
Unknown
NCT05053594Phase 4PrincipalInvestigator

Different Doses of Neostigmine for Reversal of Moderate Neuromuscular Blockade in Children

Neuromuscular Block ProlongedNeuromuscular Block, ResidualNeuromuscular Blockade
Unknown

All 3 trials loaded